Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-30 5:02 pm Purchase | 2023-10-18 | 13G | 89bio, Inc. ETNB | SUVRETTA CAPITAL MANAGEMENT, LLC | 4,808,374 6.400% | 4,808,374 (New Position) | Filing History |
| 2023-08-11 5:01 pm Sale | 2023-08-09 | 13D | 89bio, Inc. ETNB | RA CAPITAL MANAGEMENT L.P. | 12,874,814 16.700% | -2,084 (-0.02%) | Filing History |
| 2023-03-30 5:02 pm Purchase | 2023-03-28 | 13D | 89bio, Inc. ETNB | RA CAPITAL MANAGEMENT L.P. | 12,876,898 18.000% | 3,500,496 (+37.33%) | Filing History |
| 2023-03-24 4:43 pm Sale | 2023-03-22 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 0 0.000% | -1,504,436 (Position Closed) | Filing History |
| 2023-02-14 5:03 pm Sale | 2022-12-31 | 13G | 89bio, Inc. ETNB | JANUS HENDERSON GROUP PLC JHG | 2,709,519 5.600% | -670,761 (-19.84%) | Filing History |
| 2023-02-14 4:58 pm Sale | 2022-12-31 | 13G | 89bio, Inc. ETNB | Great Point Partners, LLC | 700,000 1.370% | -1,400,000 (-66.67%) | Filing History |
| 2023-02-14 4:51 pm Purchase | 2022-06-30 | 13G | 89bio, Inc. ETNB | JANUS HENDERSON GROUP PLC JHG | 3,380,280 8.300% | 3,380,280 (New Position) | Filing History |
| 2023-02-14 4:18 pm Purchase | 2022-12-31 | 13D | 89bio, Inc. ETNB | Longitude Capital Partners III LLC | 1,233,399 2.600% | 10,666 (+0.87%) | Filing History |
| 2023-02-14 12:00 pm Sale | 2022-12-31 | 13G | 89bio, Inc. ETNB | BIOTECHNOLOGY VALUE FUND L P | 3,521,126 6.500% | -376,874 (-9.67%) | Filing History |
| 2023-02-09 08:31 am Purchase | 2022-12-31 | 13G | 89bio, Inc. ETNB | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,692,549 7.220% | 1,002,549 (+37.27%) | Filing History |
| 2023-01-26 4:40 pm Sale | 2023-01-24 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 1,504,436 3.200% | -325,000 (-17.77%) | Filing History |
| 2022-12-29 4:15 pm Purchase | 2022-12-19 | 13G | 89bio, Inc. ETNB | Cormorant Asset Management, LP | 2,550,000 5.480% | 2,550,000 (New Position) | Filing History |
| 2022-10-21 06:03 am Purchase | 2022-10-18 | 13D | 89bio, Inc. ETNB | RA CAPITAL MANAGEMENT L.P. | 9,376,402 19.900% | 1,570,233 (+20.12%) | Filing History |
| 2022-08-12 5:28 pm Purchase | 2022-07-29 | 13G | 89bio, Inc. ETNB | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,690,000 6.800% | 2,690,000 (New Position) | Filing History |
| 2022-07-11 5:03 pm Purchase | 2022-06-29 | 13G | 89bio, Inc. ETNB | BIOTECHNOLOGY VALUE FUND L P | 3,898,000 9.990% | 3,898,000 (New Position) | Filing History |
| 2022-07-08 5:13 pm Purchase | 2022-06-29 | 13G | 89bio, Inc. ETNB | Great Point Partners, LLC | 2,100,000 5.290% | 2,100,000 (New Position) | Filing History |
| 2022-07-07 09:24 am Purchase | 2022-06-29 | 13G | 89bio, Inc. ETNB | Deep Track Capital, LP | 4,331,499 9.990% | 4,331,499 (New Position) | Filing History |
| 2022-07-06 5:25 pm Purchase | 2009-02-28 | 13D | 89bio, Inc. ETNB | RA CAPITAL MANAGEMENT L.P. | 7,806,169 19.900% | 2,840,400 (+57.20%) | Filing History |
| 2022-07-05 4:30 pm Sale | 2022-07-05 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 1,829,436 4.700% | -35,285 (-1.89%) | Filing History |
| 2022-06-10 10:14 am Sale | 2022-05-31 | 13G | 89bio, Inc. ETNB | Wellington Management Group LLP | 0 0.000% | -2,150,475 (Position Closed) | Filing History |